This photo taken on Dec 22, 2020 shows the production line of the Russian "Sputnik V" COVID-19 vaccine at a pharmaceutical plant in the Karaganda Region of Kazakhstan. (KALIZHAN OSPANOV / XINHUA)
Russia’s RDIF sovereign wealth fund said on Monday it had agreed with Hualan Biological Bacterin to produce more than 100 million doses of the Sputnik V vaccine against COVID-19 in China.
RDIF said the two sides were committed to a long-term partnership in vaccine production.
Copyright 1995 - 2021. All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily. Without written authorization from China Daily, such content shall not be republished or used in any form.
HONG KONG NEWS